SlideShare a Scribd company logo
Hyponatremia
Practical Approach
Mohammed Abdel Gawad
Nephrology Consultant - Alexandria - Egypt
MD Nephrology - Mansoura University
European Specialty Examination in Nephrology (ESENeph)
NephroTube Founder/Admin
Member of ISN education SoMe team
Co-chair of AFRAN Web & Media Committee
drgawad@gmail.com
@Gawad_Nephro
NephroTube Webinar, 01-July-2021
To download the lecture contact me
drgawad@gmail.com
For more Nephrology lectures visit
www.NephroTube.com
Visit
www.NephroTube.com
for more lectures
Normal serum sodium
135-145 mEq/L (mmol/L)
Hyponatremia serum sodium
< 135 mEq/L (mmol/L)
the most common disorder of body fluid and
electrolyte balance encountered in clinical practice
• Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Clinical Endocrinology 2007 66 367–372
• Upadhyay A, Jaber BL, Madias NE. Seminars in Nephrology 2009 29 227–238
Fluid Compartments
POTASSIUM SODIUM
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Hyponatremia is primarily a
disorder of water balance
Relative excess of body water compared to
total body sodium and potassium content
H2O > Na
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Hyponatremia
Clinical Presentation
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
The presence of these symptoms and their severity depend
on both the MAGNITUDE of the hyponatremia and the
RATE at which the hyponatremia developed
Hyponatremia
Pathogenesis of Central Effect
M.Gawad www.nephrotubecne.com
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Normally: ICF Osmolality = ECF Osmolality
Intracellular Extracellular
Hyponatremia
Pathogenesis of Central Effect
Hyponatremia: ICF Osmolality > ECF Osmolality
Intracellular Extracellular
Intracellular
swelling &
edema
H2O
M.Gawad www.nephrotubecne.com
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Hyponatremia
Pathogenesis of Central Effect
Hyponatremia: ICF Osmolality > ECF Osmolality
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Hyponatremia
How brain adapt hyponatremia ??
(especially chronic cases)
Hyponatremia
How brain adapt hyponatremia ??
(especially chronic cases)
Maximal compensation for a
decrease in plasma osmolality
typically requires up to
48 hours.
Adrogue HJ & Madias NE. Hyponatremia. NEJM 2000 342 1581–1589.
Avoid rapid correction of
hyponatremia
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Repeat serum Na
The level should be repeated to rule out:
– Lab error.
– blood-drawing error.
Precautions of sample taking:
– the blood should be drawn through the
skin (not from an IV line).
– the blood should be drawn from a vein that
does not have IV fluids flowing through it.
Repeat serum Na
Exclude Drugs
What is the next step?
What is the relation between
Na and Plasma Osmolality?
Normally ranges between 275 and 295 mmol/L
Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders,
5th ed, McGraw-Hill, New York 2001. p.699.
Translocational
Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders,
5th ed, McGraw-Hill, New York 2001. p.699.
Exclude Pseudo &
Translocational Hyponatremia
Translocational
True vs Pseudo - Hyponatremia
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
In which compartment of the following we are
measuring sodium concentration ??
Blood
5 liters
Plasma
55%, 3 liters
Water 90%
Lipids, proteins &
other inorganic
substances
Cellular
elements
45%, 2 liters
RBCs WBCs Platelets
Pseudohyponatremia
(Normal Plasma Osmolality)
Introduction
TAKE CARE it is:
Na CONCENTRATION, Not Na LEVEL
Pseudohyponatremia
(Normal Plasma Osmolality)
Introduction
Hyperlipidemia &
Hyperproteinemia
True vs Pseudo - Hyponatremia
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Na is here
Flame
photometry
measure Na in
relation to all
compartments
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
Water +
Na
Proteins,
Lipids
Cells
Na conc to
water = 50%
Na conc to
plasma =
35% Water +
Na
Proteins,
Lipids
Cells
Na conc to
water = 50%
Na conc to
plasma =
15%
The above numbers are not true values, they are only for demonstration
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
M.Gawad www.nephrotube.com
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
The traditional method of measuring the
sodium concentration in plasma flame
photometry uses the entire volume of the
sample, which includes both the aqueous
and nonaqueous phases of plasma.
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
Therefore, for patients with marked
elevations in plasma lipids or plasma
proteins, ask the hospital laboratory to use
an ion-specific electrode to measure the
plasma sodium concentration.
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Pseudohyponatraemia still occurs despite
the use of ion-selective electrodes
Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
Serum Na x 93
99 – 1.03 (triglyceride gm/L) – 0.73 (protein gm/L)
Corrected Na =
Pseudohyponatremia
(Normal Plasma Osmolality)
Hyperlipidemia & Hyperproteinemia
Stephen Sigworth, MD, MSHA. Sodium Disorders
Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders,
5th ed, McGraw-Hill, New York 2001. p.699.
Translocational
Translocational- Hyponatremia
(High Plasma Osmolality)
High Serum Glucose or
Hypertonic Infusions
•Carlotti AP et al. Intensive Care Medicine 2001 27 921–924
•Oster JR et al. Archives of Internal Medicine 1999 159 333–336
•Hillier TA et al. American Journal of Medicine 1999 106 399–403
Translocational
Translocational Hyponatremia
(High Plasma Osmolality)
Here Na is truly low
(i.e. not lab error),
but
plasma osmolality is high
Handbook of Critical Care Nephrology. Chapter 19. 2021
Carlotti AP et al. Intensive Care Medicine 2001 27 921–924
Hypertonic
Infusions
Adjusted sodium = Na + 1.6 × (glucose/100)
How to differentiate between 3 types
of hyponatremia?
Logic = Measure Plasma Osmolality
Translocational
Serum Cholesterol,
TG,
Total proteins
History,
Blood glucose
Translocational
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Repeat serum Na
Exclude Drugs
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
H2O > Na
True Hyponatremia Cause?
Adrogue HJ, Madias NE. Clinical Endocrinology 2000 52 667–678
5
Hoorn EJ et al. QJM: Monthly Journal of the Association of Physicians 2005 98 529–540
True Hyponatremia Cause?
5
Clinical assessment of volume status ?!
Generally not very accurate
Likely to lead to misclassification of hyponatraemia
Low sensitivity (0.5–0.8) and specificity (0.3–0.5)
Algorithms that start with a clinical
assessment of volume status are not accurate
Hoorn EJ et al. QJM: Monthly Journal of the Association of Physicians 2005 98 529–540
True Hyponatremia Cause?
5
Start with urine osmolality
and sodium concentration
(best determined in the same urine
sample)
Use the terms:
a- Effective circulating volume
b- Extracellular fluid volume
Instead of hyper, hypo,
euo - volumic
This diagnostic tree is a simplification and
does not guarantee completeness in each
individual
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
5
SIAD is a diagnosis of exclusion
Janicic N et al. Endocrinology and Metabolism Clinics of North America 2003 32 459–481
SIAD is a diagnosis of exclusion
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
5
https://emedicine.medscape.com
/article/919609-overview
May 13, 2020
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Kidney International (2009) 76, 934–938
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
5
RENAL SALT WASTING
The overwhelming majority of patients in the neurosurgical setting with
hyponatremia after subarachnoid hemorrhage, trauma, or surgery have
SIADH, not CSW
Handbook of Critical Care Nephrology. Chapter 19. 2021
Patients who develop hemodynamic instability and frank volume depletion
in response to fluid restriction have CSW, and patients whose urine volume
decreases and sodium improves with fluid restriction have SIADH
Handbook of Critical Care Nephrology. Chapter 19. 2021
Kidney International (2009) 76, 934–938
occasional increase in FEphosphate >20% in RSW
FEphosphate should be
determined before administering saline
Kidney International (2009) 76, 934–938
SIADH RSW/CSW
Volume before treatment Euvolemia Hypovolemia
(orthostatic hypotension)
FEphosphate before
administering saline
Normal ± >20%
hemodynamic instability
and frank volume
depletion with fluid
restriction
No Yes
After correction of
hyponatremia
Kidney International (2009) 76, 934–938
Repeat serum Na
Exclude Drugs
4
5
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
5
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
General rules – 0.9% or 3% NaCl infusion
Maximum correction limit (i.e. Stop infusion when)
10 mmol/l in the
first 24 h
8 mmol/l during
every 24 h
thereafter
130 mmol/l is
reached or
serum sodium
concentration
increases
10 mmol/l in
total
symptoms
improved
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
General rules – 0.9% or 3% NaCl infusion
Maximum correction limit (i.e. Stop infusion when)
10 mmol/l in the
first 24 h
8 mmol/l during
every 24 h
thereafter
130 mmol/l is
reached or
serum sodium
concentration
increases
10 mmol/l in
total
symptoms
improved
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
If the symptoms still have not improved, it is unlikely that
the symptoms are due to the hyponatremia and
alternative explanations should be sought
Handbook of Critical Care Nephrology. Chapter 19. 2021
Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Total Body Water Assessment (TBW)
men <70 years old 0.6 × body weight
men ≥70 years old
women <70 years old
0.5 × body weight
women ≥70 years old 0.45 × body weight
Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Keep in mind that if hypokalaemia is
present, correction of the hypokalaemia
will contribute to an increase in serum
sodium concentration.
Kamel KS, Bear RA. Am J Kidney Dis. 1993;21(4):439.
Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Keep in mind that if hypokalaemia is
present, correction of the hypokalaemia
will contribute to an increase in serum
sodium concentration.
Kamel KS, Bear RA. Am J Kidney Dis. 1993;21(4):439.
Case Rep Nephrol. 2017; 2017: 4521319
Adrogué–Madias Formula
Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
Adrogué–Madias Formula
Anesthesiology Clin N Am 20 (2002) 329–346
Adrogué–Madias Formula
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Severe Symptoms
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
Maximum:
Repeat twice
Maximum:
5 mmol/l
increase
A. Improvement of
symptoms
→ Stop 3% infusion
B. No improvement
of symptoms
→ continue infusion
targeting general
rules of raising
serum Na
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
keep the i.v. line
open by infusing the
smallest feasible
volume of 0.9%
saline until cause-
specific treatment is
started
First-hour management:
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Moderate Symptoms
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
A. Improvement of
symptoms
→ Stop 3% infusion
B. No improvement
of symptoms
→ continue infusion
targeting general
rules of raising
serum Na
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
keep the i.v. line
open by infusing the
smallest feasible
volume of 0.9%
saline until cause-
specific treatment is
started
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Acute presentation
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
If the acute decrease in serum sodium concentration exceeds 10 mmol/l
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Chronic presentation
Reduced Circulating volume
targeting general
rules of raising
serum Na
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
JAMA. 2007;297(12):1319-1331
• Increased number of deaths in those patients treated with
vasopressin receptor antagonists in comparison with those treated
with placebo.
• Vasopressin receptor antagonists may actually worsen outcomes.
• Rozen-Zvi B et al. American Journal of Kidney Diseases 2010 56 325–337
• Jaber BL et al. American Journal of Medicine 2011 124 971–979
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
JAMA. 2007;297(12):1319-1331
• Increased number of deaths in those patients treated with
vasopressin receptor antagonists in comparison with those treated
with placebo.
• Vasopressin receptor antagonists may actually worsen outcomes.
• Rozen-Zvi B et al. American Journal of Kidney Diseases 2010 56 325–337
• Jaber BL et al. American Journal of Medicine 2011 124 971–979
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Heart Faliure: ADH receptor antagonists, either intravenous (IV) conivaptan
or oral tolvaptan, would be appropriate agents to increase serum sodium
although they have not been shown to improve heart failure outcomes
JAMA. 2007;297(12):1319-1331
The side effects reported for demeclocycline and lithium were
such that we recommend not using them for any degree of
hyponatraemia.
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Management – Chronic presentation
Circulating volume Expanded
ECF Expanded
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
consider furosemide
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Symptomatic?
Yes
Severe
Moderately
severe
No
Acute Chronic
Circulating volume
Reduced
Circulating volume
Not Reduced
ECF
expanded
ECF not
expanded
Management - Algorithm
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Rapid Correction of Hyponatremia
Bad Effect
Rare but dramatic complication
Osmotic demyelination syndrome
Rapid correction of Na
=
Rapid increase in plasma
osmolality
Rapid shift of
water form
intracellular
space
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Handbook of Critical Care Nephrology. Chapter 19. 2021
Consideration should be given to correcting the sodium even
slower
Handbook of Critical Care Nephrology. Chapter 19. 2021
Consideration should be given to correcting the sodium even
slower
In some situations, specific treatments of hyponatremia are so
effective that patients will autocorrect their hyponatremia faster
than 8 mmol/L/d
• psychogenic polydipsia
• tea and toast syndrome
• volume depletion
• thiazide-induced hyponatremia
• adrenal insufficiency
Cases of ODS despite guideline-based
correction speeds have been reported
Eur J Endocrinol. 2014;170(3):G1-G47.
Cureus. 2020;12(1):e6547.
Rapid Correction of Hyponatremia
Bad Effect
Rare but dramatic complication
Osmotic demyelination syndrome
Diagnosis:
The lesions are detectable by both CT scan and MRI. MRI is
more sensitive (because it is better able to visualize the brain
stem and is more sensitive to changes in the white matter).
Timing is critical in diagnostic studies because lesions do not
become apparent for up to four weeks. Because of this delay,
an initially negative study does not rule out.
Harring TR, Deal NS, Kuo DC. Emerg Med Clin North Am. 2014 May;32(2):379-401.
Rapid Correction of Hyponatremia
What to do?
Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
If increases >10 mmol/l during the first 24 h or >8 mmol/l in
any 24 h thereafter
Discontinuing the ongoing
active treatment (1D).
Consulting an expert to
discuss if it is appropriate to
start an infusion of 10 ml/kg
body weight of electrolyte-
free water (e.g. glucose
solutions) over 1 h under
strict monitoring of urine
output and fluid balance (1D).
Consulting an expert to
discuss if it is appropriate to
add i.v. desmopressin 2 μg,
with the understanding that
this should not be repeated
more frequently than every
8h (1D).
A more proactive approach is to start DDAVP at the outset of the
treatment of hyponatremia; this is called a DDAVP clamp
Rapid Correction of Hyponatremia
How to avoid?
Handbook of Critical Care Nephrology. Chapter 19. 2021
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Talk Outline
• Presentation
• Diagnosis
• Management:
–General rules
–Stepwise approach
–Overcorrection
–Dialysis of Hyponatremic Patient
Hyponatremia in a Patient on Hemodialysis
How to Manage?
Plasma Na level
of the patient
Daugirdas, JT, Ross, et al. Acute hemodialysis Prescription. In:
Handbook of Dialysis, Philadelphia 2007
Dialysate sodium
concentration
Maximum difference
15-20 mEq
Hyponatremia in a Patient on Hemodialysis
How to Manage?
Concurrent infusions
of 5 % dextrose
(D5W)
Every 1L of D5W will
decrease serum
sodium concentration
by 3.5 mEq / L
Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342(20):1493-1499.
CRRT may also be used to safely correct hyponatremia.
CRRT is less efficient in the rate at which serum sodium is
changed and results in a more gradual correction over a
longer time span
Am J Kidney Dis. 2014;64:305.
Hyponatremia in a Patient on Hemodialysis
How to Manage?
Uremia may provide some protection against
osmotic demyelination
Rapid correction of Na
=
Rapid increase in plasma
osmolality
High
intracellular
urea level
Home Messages
The presence of symptoms and their severity depend on
both the MAGNITUDE of the hyponatremia and the
RATE at which the hyponatremia developed
Home Messages
Normal Maximal compensation for a decrease in plasma
osmolality typically requires up to 48 hours.
Avoid rapid correction of hyponatremia
Home Messages
3% NaCl infusion is mandatory in:
- Severe symptoms
- Moderate symptoms
- Acute presentation
Home Messages
Uremia may provide some protection against
osmotic demyelination
Home Messages
Hyponatremia (Practical Approach) - Dr. Gawad

More Related Content

What's hot

Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. GawadRhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
NephroTube - Dr.Gawad
 
Contrast induced AKI
Contrast induced AKIContrast induced AKI
Contrast induced AKI
Amit Gulati
 
Anemia in ckd
Anemia in ckd Anemia in ckd
Anemia in ckd
Dr Ramesh Krishnan
 
A new perspective on hyponatremia
A new perspective on hyponatremiaA new perspective on hyponatremia
A new perspective on hyponatremia
Steve Chen
 
Hyponatremia (1)
Hyponatremia (1)Hyponatremia (1)
Hyponatremia (1)
Praveen Maurya
 
ESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. Gawad
NephroTube - Dr.Gawad
 
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
NephroTube - Dr.Gawad
 
Fluid Therapy In AKI
Fluid Therapy In AKI Fluid Therapy In AKI
Fluid Therapy In AKI
MNDU net
 
Intra dialytic hypotension ,,, prof Alaa Sabry
Intra dialytic hypotension ,,,  prof Alaa SabryIntra dialytic hypotension ,,,  prof Alaa Sabry
Intra dialytic hypotension ,,, prof Alaa Sabry
FarragBahbah
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
AKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. GawadAKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome
Ade Wijaya
 
Hypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. GawadHypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
AIIMS, New Delhi, India
 
Approach to hyponatremia
Approach to hyponatremiaApproach to hyponatremia
Approach to hyponatremia
mahendra maske
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
NephroTube - Dr.Gawad
 
Anemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of viewAnemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of view
MNDU net
 

What's hot (20)

Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. GawadRhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
 
Contrast induced AKI
Contrast induced AKIContrast induced AKI
Contrast induced AKI
 
Anemia in ckd
Anemia in ckd Anemia in ckd
Anemia in ckd
 
A new perspective on hyponatremia
A new perspective on hyponatremiaA new perspective on hyponatremia
A new perspective on hyponatremia
 
Hyponatremia (1)
Hyponatremia (1)Hyponatremia (1)
Hyponatremia (1)
 
ESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. Gawad
 
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
 
Fluid Therapy In AKI
Fluid Therapy In AKI Fluid Therapy In AKI
Fluid Therapy In AKI
 
Intra dialytic hypotension ,,, prof Alaa Sabry
Intra dialytic hypotension ,,,  prof Alaa SabryIntra dialytic hypotension ,,,  prof Alaa Sabry
Intra dialytic hypotension ,,, prof Alaa Sabry
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
 
AKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. GawadAKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. Gawad
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
 
Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome
 
Hypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. GawadHypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. Gawad
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
 
Approach to hyponatremia
Approach to hyponatremiaApproach to hyponatremia
Approach to hyponatremia
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
 
Anemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of viewAnemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of view
 

Similar to Hyponatremia (Practical Approach) - Dr. Gawad

Hyponatremia 2015 final
Hyponatremia 2015 finalHyponatremia 2015 final
Hyponatremia 2015 final
Ayman Seddik
 
Balanced solution is a boon for fluid resuscitation
Balanced solution is a boon for fluid resuscitationBalanced solution is a boon for fluid resuscitation
Balanced solution is a boon for fluid resuscitation
dr nirmal jaiswal
 
Life Threatening Asthma - Some Pearls and Pitfalls
Life Threatening Asthma - Some Pearls and PitfallsLife Threatening Asthma - Some Pearls and Pitfalls
Life Threatening Asthma - Some Pearls and Pitfalls
Chew Keng Sheng
 
Tolvaptan cme slide
Tolvaptan cme slideTolvaptan cme slide
Tolvaptan cme slide
Raja Lahiri
 
Block1 pgy451-renal-awayda
Block1 pgy451-renal-awaydaBlock1 pgy451-renal-awayda
Block1 pgy451-renal-awayda
jacordob
 
Renal replacement therapy in intensive care
Renal replacement therapy in intensive careRenal replacement therapy in intensive care
Renal replacement therapy in intensive careAndrew Ferguson
 
Eletro Stimulation of Lower Esophageal Sphincter on GERD treatment
Eletro Stimulation of Lower Esophageal Sphincter  on GERD treatment  Eletro Stimulation of Lower Esophageal Sphincter  on GERD treatment
Eletro Stimulation of Lower Esophageal Sphincter on GERD treatment
Manoel Galvao Neto
 
Uremic toxins prof. alaa sabry
Uremic toxins    prof. alaa sabryUremic toxins    prof. alaa sabry
Uremic toxins prof. alaa sabry
FarragBahbah
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
MuhammadThaifur1
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
NekHang
 
Osmoregulation (Urine Dilution & Concentration) - Dr. Gawad
Osmoregulation (Urine Dilution & Concentration) - Dr. GawadOsmoregulation (Urine Dilution & Concentration) - Dr. Gawad
Osmoregulation (Urine Dilution & Concentration) - Dr. Gawad
NephroTube - Dr.Gawad
 
Prof. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with akiProf. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with aki
wessam1071
 
Acute Kidney Injury in fever.pptx
Acute Kidney Injury in fever.pptxAcute Kidney Injury in fever.pptx
Acute Kidney Injury in fever.pptxDrTapasTripathi
 
Dr chandrashekar 2016 sodium disturbances
Dr chandrashekar 2016 sodium  disturbancesDr chandrashekar 2016 sodium  disturbances
Dr chandrashekar 2016 sodium disturbances
intentdoc
 
Volume overhydration in dialysis patients
Volume overhydration in dialysis patientsVolume overhydration in dialysis patients
Volume overhydration in dialysis patients
doremi78
 
NIV in NM Disease
NIV in NM Disease NIV in NM Disease
NIV in NM Disease
Meredith Huang
 
Acute Kidney Injury in Dengue Fever.pptx
Acute Kidney Injury in Dengue Fever.pptxAcute Kidney Injury in Dengue Fever.pptx
Acute Kidney Injury in Dengue Fever.pptx
Junaid Khan
 
Anemia mih
Anemia  mihAnemia  mih
Anemia mih
FarragBahbah
 
Hyperuricemia in CKD
Hyperuricemia in CKDHyperuricemia in CKD
Hyperuricemia in CKD
Sidney Erwin Manahan
 
Reducing Oxidative Stress | Revelar
Reducing Oxidative Stress | RevelarReducing Oxidative Stress | Revelar
Reducing Oxidative Stress | Revelar
MyRevelar
 

Similar to Hyponatremia (Practical Approach) - Dr. Gawad (20)

Hyponatremia 2015 final
Hyponatremia 2015 finalHyponatremia 2015 final
Hyponatremia 2015 final
 
Balanced solution is a boon for fluid resuscitation
Balanced solution is a boon for fluid resuscitationBalanced solution is a boon for fluid resuscitation
Balanced solution is a boon for fluid resuscitation
 
Life Threatening Asthma - Some Pearls and Pitfalls
Life Threatening Asthma - Some Pearls and PitfallsLife Threatening Asthma - Some Pearls and Pitfalls
Life Threatening Asthma - Some Pearls and Pitfalls
 
Tolvaptan cme slide
Tolvaptan cme slideTolvaptan cme slide
Tolvaptan cme slide
 
Block1 pgy451-renal-awayda
Block1 pgy451-renal-awaydaBlock1 pgy451-renal-awayda
Block1 pgy451-renal-awayda
 
Renal replacement therapy in intensive care
Renal replacement therapy in intensive careRenal replacement therapy in intensive care
Renal replacement therapy in intensive care
 
Eletro Stimulation of Lower Esophageal Sphincter on GERD treatment
Eletro Stimulation of Lower Esophageal Sphincter  on GERD treatment  Eletro Stimulation of Lower Esophageal Sphincter  on GERD treatment
Eletro Stimulation of Lower Esophageal Sphincter on GERD treatment
 
Uremic toxins prof. alaa sabry
Uremic toxins    prof. alaa sabryUremic toxins    prof. alaa sabry
Uremic toxins prof. alaa sabry
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
 
Osmoregulation (Urine Dilution & Concentration) - Dr. Gawad
Osmoregulation (Urine Dilution & Concentration) - Dr. GawadOsmoregulation (Urine Dilution & Concentration) - Dr. Gawad
Osmoregulation (Urine Dilution & Concentration) - Dr. Gawad
 
Prof. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with akiProf. a. el sebaeii.fluid management in patients with aki
Prof. a. el sebaeii.fluid management in patients with aki
 
Acute Kidney Injury in fever.pptx
Acute Kidney Injury in fever.pptxAcute Kidney Injury in fever.pptx
Acute Kidney Injury in fever.pptx
 
Dr chandrashekar 2016 sodium disturbances
Dr chandrashekar 2016 sodium  disturbancesDr chandrashekar 2016 sodium  disturbances
Dr chandrashekar 2016 sodium disturbances
 
Volume overhydration in dialysis patients
Volume overhydration in dialysis patientsVolume overhydration in dialysis patients
Volume overhydration in dialysis patients
 
NIV in NM Disease
NIV in NM Disease NIV in NM Disease
NIV in NM Disease
 
Acute Kidney Injury in Dengue Fever.pptx
Acute Kidney Injury in Dengue Fever.pptxAcute Kidney Injury in Dengue Fever.pptx
Acute Kidney Injury in Dengue Fever.pptx
 
Anemia mih
Anemia  mihAnemia  mih
Anemia mih
 
Hyperuricemia in CKD
Hyperuricemia in CKDHyperuricemia in CKD
Hyperuricemia in CKD
 
Reducing Oxidative Stress | Revelar
Reducing Oxidative Stress | RevelarReducing Oxidative Stress | Revelar
Reducing Oxidative Stress | Revelar
 

More from NephroTube - Dr.Gawad

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
NephroTube - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
NephroTube - Dr.Gawad
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
NephroTube - Dr.Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
NephroTube - Dr.Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
NephroTube - Dr.Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
NephroTube - Dr.Gawad
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
NephroTube - Dr.Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
NephroTube - Dr.Gawad
 
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. GawadAVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
NephroTube - Dr.Gawad
 

More from NephroTube - Dr.Gawad (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
 
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. GawadAVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
AVF/AVG Monitoring and Examination (Applied Clinical Cases) - Dr. Gawad
 

Recently uploaded

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 

Recently uploaded (20)

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 

Hyponatremia (Practical Approach) - Dr. Gawad

  • 1. Hyponatremia Practical Approach Mohammed Abdel Gawad Nephrology Consultant - Alexandria - Egypt MD Nephrology - Mansoura University European Specialty Examination in Nephrology (ESENeph) NephroTube Founder/Admin Member of ISN education SoMe team Co-chair of AFRAN Web & Media Committee drgawad@gmail.com @Gawad_Nephro NephroTube Webinar, 01-July-2021
  • 2. To download the lecture contact me drgawad@gmail.com For more Nephrology lectures visit www.NephroTube.com
  • 4.
  • 5. Normal serum sodium 135-145 mEq/L (mmol/L) Hyponatremia serum sodium < 135 mEq/L (mmol/L) the most common disorder of body fluid and electrolyte balance encountered in clinical practice • Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Clinical Endocrinology 2007 66 367–372 • Upadhyay A, Jaber BL, Madias NE. Seminars in Nephrology 2009 29 227–238
  • 7. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Hyponatremia is primarily a disorder of water balance Relative excess of body water compared to total body sodium and potassium content H2O > Na
  • 8. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 9. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 10. Hyponatremia Clinical Presentation Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 The presence of these symptoms and their severity depend on both the MAGNITUDE of the hyponatremia and the RATE at which the hyponatremia developed
  • 11. Hyponatremia Pathogenesis of Central Effect M.Gawad www.nephrotubecne.com Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Normally: ICF Osmolality = ECF Osmolality Intracellular Extracellular
  • 12. Hyponatremia Pathogenesis of Central Effect Hyponatremia: ICF Osmolality > ECF Osmolality Intracellular Extracellular Intracellular swelling & edema H2O M.Gawad www.nephrotubecne.com Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 13. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Hyponatremia Pathogenesis of Central Effect Hyponatremia: ICF Osmolality > ECF Osmolality
  • 14. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Hyponatremia How brain adapt hyponatremia ?? (especially chronic cases)
  • 15. Hyponatremia How brain adapt hyponatremia ?? (especially chronic cases) Maximal compensation for a decrease in plasma osmolality typically requires up to 48 hours. Adrogue HJ & Madias NE. Hyponatremia. NEJM 2000 342 1581–1589. Avoid rapid correction of hyponatremia
  • 16. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 17. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 18. Repeat serum Na The level should be repeated to rule out: – Lab error. – blood-drawing error. Precautions of sample taking: – the blood should be drawn through the skin (not from an IV line). – the blood should be drawn from a vein that does not have IV fluids flowing through it.
  • 20. What is the next step? What is the relation between Na and Plasma Osmolality? Normally ranges between 275 and 295 mmol/L
  • 21. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.699. Translocational
  • 22. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.699. Exclude Pseudo & Translocational Hyponatremia Translocational
  • 23. True vs Pseudo - Hyponatremia Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
  • 24. In which compartment of the following we are measuring sodium concentration ?? Blood 5 liters Plasma 55%, 3 liters Water 90% Lipids, proteins & other inorganic substances Cellular elements 45%, 2 liters RBCs WBCs Platelets Pseudohyponatremia (Normal Plasma Osmolality) Introduction
  • 25. TAKE CARE it is: Na CONCENTRATION, Not Na LEVEL Pseudohyponatremia (Normal Plasma Osmolality) Introduction
  • 26. Hyperlipidemia & Hyperproteinemia True vs Pseudo - Hyponatremia Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
  • 27. Pseudohyponatremia (Normal Plasma Osmolality) Hyperlipidemia & Hyperproteinemia Na is here Flame photometry measure Na in relation to all compartments Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
  • 28. Water + Na Proteins, Lipids Cells Na conc to water = 50% Na conc to plasma = 35% Water + Na Proteins, Lipids Cells Na conc to water = 50% Na conc to plasma = 15% The above numbers are not true values, they are only for demonstration Pseudohyponatremia (Normal Plasma Osmolality) Hyperlipidemia & Hyperproteinemia M.Gawad www.nephrotube.com Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
  • 29. The traditional method of measuring the sodium concentration in plasma flame photometry uses the entire volume of the sample, which includes both the aqueous and nonaqueous phases of plasma. Pseudohyponatremia (Normal Plasma Osmolality) Hyperlipidemia & Hyperproteinemia Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
  • 30. Therefore, for patients with marked elevations in plasma lipids or plasma proteins, ask the hospital laboratory to use an ion-specific electrode to measure the plasma sodium concentration. Pseudohyponatremia (Normal Plasma Osmolality) Hyperlipidemia & Hyperproteinemia Pseudohyponatraemia still occurs despite the use of ion-selective electrodes Turchin A, Seifter JL, Seely EW. New England Journal of Medicine 2003 349 1465–1469
  • 31. Serum Na x 93 99 – 1.03 (triglyceride gm/L) – 0.73 (protein gm/L) Corrected Na = Pseudohyponatremia (Normal Plasma Osmolality) Hyperlipidemia & Hyperproteinemia Stephen Sigworth, MD, MSHA. Sodium Disorders
  • 32. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.699. Translocational
  • 33. Translocational- Hyponatremia (High Plasma Osmolality) High Serum Glucose or Hypertonic Infusions •Carlotti AP et al. Intensive Care Medicine 2001 27 921–924 •Oster JR et al. Archives of Internal Medicine 1999 159 333–336 •Hillier TA et al. American Journal of Medicine 1999 106 399–403 Translocational
  • 34. Translocational Hyponatremia (High Plasma Osmolality) Here Na is truly low (i.e. not lab error), but plasma osmolality is high Handbook of Critical Care Nephrology. Chapter 19. 2021 Carlotti AP et al. Intensive Care Medicine 2001 27 921–924 Hypertonic Infusions Adjusted sodium = Na + 1.6 × (glucose/100)
  • 35. How to differentiate between 3 types of hyponatremia? Logic = Measure Plasma Osmolality Translocational
  • 36.
  • 37. Serum Cholesterol, TG, Total proteins History, Blood glucose Translocational Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 38. Repeat serum Na Exclude Drugs 5 Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 39. Repeat serum Na Exclude Drugs 4 5 Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 40. Repeat serum Na Exclude Drugs 4 5 Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 41. Repeat serum Na Exclude Drugs 4 5 Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 42. H2O > Na True Hyponatremia Cause? Adrogue HJ, Madias NE. Clinical Endocrinology 2000 52 667–678 5
  • 43. Hoorn EJ et al. QJM: Monthly Journal of the Association of Physicians 2005 98 529–540 True Hyponatremia Cause? 5
  • 44. Clinical assessment of volume status ?! Generally not very accurate Likely to lead to misclassification of hyponatraemia Low sensitivity (0.5–0.8) and specificity (0.3–0.5) Algorithms that start with a clinical assessment of volume status are not accurate Hoorn EJ et al. QJM: Monthly Journal of the Association of Physicians 2005 98 529–540 True Hyponatremia Cause? 5
  • 45. Start with urine osmolality and sodium concentration (best determined in the same urine sample) Use the terms: a- Effective circulating volume b- Extracellular fluid volume Instead of hyper, hypo, euo - volumic
  • 46. This diagnostic tree is a simplification and does not guarantee completeness in each individual Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 5
  • 47. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 5
  • 48. SIAD is a diagnosis of exclusion Janicic N et al. Endocrinology and Metabolism Clinics of North America 2003 32 459–481
  • 49. SIAD is a diagnosis of exclusion Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 50. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 5
  • 51. https://emedicine.medscape.com /article/919609-overview May 13, 2020 Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Kidney International (2009) 76, 934–938
  • 52. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 5
  • 54. The overwhelming majority of patients in the neurosurgical setting with hyponatremia after subarachnoid hemorrhage, trauma, or surgery have SIADH, not CSW Handbook of Critical Care Nephrology. Chapter 19. 2021
  • 55.
  • 56.
  • 57. Patients who develop hemodynamic instability and frank volume depletion in response to fluid restriction have CSW, and patients whose urine volume decreases and sodium improves with fluid restriction have SIADH Handbook of Critical Care Nephrology. Chapter 19. 2021
  • 59. occasional increase in FEphosphate >20% in RSW FEphosphate should be determined before administering saline Kidney International (2009) 76, 934–938
  • 60. SIADH RSW/CSW Volume before treatment Euvolemia Hypovolemia (orthostatic hypotension) FEphosphate before administering saline Normal ± >20% hemodynamic instability and frank volume depletion with fluid restriction No Yes After correction of hyponatremia Kidney International (2009) 76, 934–938
  • 61. Repeat serum Na Exclude Drugs 4 5 Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 62. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 5
  • 63. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 64. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 65. General rules – 0.9% or 3% NaCl infusion Maximum correction limit (i.e. Stop infusion when) 10 mmol/l in the first 24 h 8 mmol/l during every 24 h thereafter 130 mmol/l is reached or serum sodium concentration increases 10 mmol/l in total symptoms improved Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 66. General rules – 0.9% or 3% NaCl infusion Maximum correction limit (i.e. Stop infusion when) 10 mmol/l in the first 24 h 8 mmol/l during every 24 h thereafter 130 mmol/l is reached or serum sodium concentration increases 10 mmol/l in total symptoms improved Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 If the symptoms still have not improved, it is unlikely that the symptoms are due to the hyponatremia and alternative explanations should be sought Handbook of Critical Care Nephrology. Chapter 19. 2021
  • 67. Adrogué–Madias Formula Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
  • 68. Adrogué–Madias Formula Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589 Total Body Water Assessment (TBW) men <70 years old 0.6 × body weight men ≥70 years old women <70 years old 0.5 × body weight women ≥70 years old 0.45 × body weight
  • 69. Adrogué–Madias Formula Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589 Keep in mind that if hypokalaemia is present, correction of the hypokalaemia will contribute to an increase in serum sodium concentration. Kamel KS, Bear RA. Am J Kidney Dis. 1993;21(4):439.
  • 70. Adrogué–Madias Formula Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589 Keep in mind that if hypokalaemia is present, correction of the hypokalaemia will contribute to an increase in serum sodium concentration. Kamel KS, Bear RA. Am J Kidney Dis. 1993;21(4):439. Case Rep Nephrol. 2017; 2017: 4521319
  • 71. Adrogué–Madias Formula Adrogue HJ, Madias NE. New England Journal of Medicine 2000 342 1581–1589
  • 74. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 75. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 76. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 77. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 78. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 79. Management – Severe Symptoms IV infusion of 150 ml 3% hypertonic (2 ml/kg) in case of obviously deviant body composition 20 min check serum Na Maximum: Repeat twice Maximum: 5 mmol/l increase A. Improvement of symptoms → Stop 3% infusion B. No improvement of symptoms → continue infusion targeting general rules of raising serum Na Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 keep the i.v. line open by infusing the smallest feasible volume of 0.9% saline until cause- specific treatment is started First-hour management:
  • 80. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 81. Management – Moderate Symptoms IV infusion of 150 ml 3% hypertonic (2 ml/kg) in case of obviously deviant body composition 20 min check serum Na A. Improvement of symptoms → Stop 3% infusion B. No improvement of symptoms → continue infusion targeting general rules of raising serum Na Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 keep the i.v. line open by infusing the smallest feasible volume of 0.9% saline until cause- specific treatment is started
  • 82. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 83. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Management – Acute presentation IV infusion of 150 ml 3% hypertonic (2 ml/kg) in case of obviously deviant body composition 20 min check serum Na If the acute decrease in serum sodium concentration exceeds 10 mmol/l
  • 84. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 85. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 86. Management – Chronic presentation Reduced Circulating volume targeting general rules of raising serum Na Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 87. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 88. Management – Chronic presentation Circulating volume Expanded ECF Expanded Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 JAMA. 2007;297(12):1319-1331
  • 89. • Increased number of deaths in those patients treated with vasopressin receptor antagonists in comparison with those treated with placebo. • Vasopressin receptor antagonists may actually worsen outcomes. • Rozen-Zvi B et al. American Journal of Kidney Diseases 2010 56 325–337 • Jaber BL et al. American Journal of Medicine 2011 124 971–979 Management – Chronic presentation Circulating volume Expanded ECF Expanded Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 JAMA. 2007;297(12):1319-1331
  • 90. • Increased number of deaths in those patients treated with vasopressin receptor antagonists in comparison with those treated with placebo. • Vasopressin receptor antagonists may actually worsen outcomes. • Rozen-Zvi B et al. American Journal of Kidney Diseases 2010 56 325–337 • Jaber BL et al. American Journal of Medicine 2011 124 971–979 Management – Chronic presentation Circulating volume Expanded ECF Expanded Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Heart Faliure: ADH receptor antagonists, either intravenous (IV) conivaptan or oral tolvaptan, would be appropriate agents to increase serum sodium although they have not been shown to improve heart failure outcomes JAMA. 2007;297(12):1319-1331
  • 91. The side effects reported for demeclocycline and lithium were such that we recommend not using them for any degree of hyponatraemia. Management – Chronic presentation Circulating volume Expanded ECF Expanded Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 92. Management – Chronic presentation Circulating volume Expanded ECF Expanded Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 consider furosemide
  • 93. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 94. Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 95.
  • 96.
  • 97. Symptomatic? Yes Severe Moderately severe No Acute Chronic Circulating volume Reduced Circulating volume Not Reduced ECF expanded ECF not expanded Management - Algorithm Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 98. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 99. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 100. Rapid Correction of Hyponatremia Bad Effect Rare but dramatic complication Osmotic demyelination syndrome Rapid correction of Na = Rapid increase in plasma osmolality Rapid shift of water form intracellular space Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 101. Handbook of Critical Care Nephrology. Chapter 19. 2021 Consideration should be given to correcting the sodium even slower
  • 102. Handbook of Critical Care Nephrology. Chapter 19. 2021 Consideration should be given to correcting the sodium even slower In some situations, specific treatments of hyponatremia are so effective that patients will autocorrect their hyponatremia faster than 8 mmol/L/d • psychogenic polydipsia • tea and toast syndrome • volume depletion • thiazide-induced hyponatremia • adrenal insufficiency
  • 103. Cases of ODS despite guideline-based correction speeds have been reported Eur J Endocrinol. 2014;170(3):G1-G47. Cureus. 2020;12(1):e6547.
  • 104. Rapid Correction of Hyponatremia Bad Effect Rare but dramatic complication Osmotic demyelination syndrome Diagnosis: The lesions are detectable by both CT scan and MRI. MRI is more sensitive (because it is better able to visualize the brain stem and is more sensitive to changes in the white matter). Timing is critical in diagnostic studies because lesions do not become apparent for up to four weeks. Because of this delay, an initially negative study does not rule out. Harring TR, Deal NS, Kuo DC. Emerg Med Clin North Am. 2014 May;32(2):379-401.
  • 105. Rapid Correction of Hyponatremia What to do? Goce Spasovski et al, Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 If increases >10 mmol/l during the first 24 h or >8 mmol/l in any 24 h thereafter Discontinuing the ongoing active treatment (1D). Consulting an expert to discuss if it is appropriate to start an infusion of 10 ml/kg body weight of electrolyte- free water (e.g. glucose solutions) over 1 h under strict monitoring of urine output and fluid balance (1D). Consulting an expert to discuss if it is appropriate to add i.v. desmopressin 2 μg, with the understanding that this should not be repeated more frequently than every 8h (1D).
  • 106. A more proactive approach is to start DDAVP at the outset of the treatment of hyponatremia; this is called a DDAVP clamp Rapid Correction of Hyponatremia How to avoid? Handbook of Critical Care Nephrology. Chapter 19. 2021
  • 107. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 108. Talk Outline • Presentation • Diagnosis • Management: –General rules –Stepwise approach –Overcorrection –Dialysis of Hyponatremic Patient
  • 109. Hyponatremia in a Patient on Hemodialysis How to Manage? Plasma Na level of the patient Daugirdas, JT, Ross, et al. Acute hemodialysis Prescription. In: Handbook of Dialysis, Philadelphia 2007 Dialysate sodium concentration Maximum difference 15-20 mEq
  • 110. Hyponatremia in a Patient on Hemodialysis How to Manage? Concurrent infusions of 5 % dextrose (D5W) Every 1L of D5W will decrease serum sodium concentration by 3.5 mEq / L Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342(20):1493-1499.
  • 111. CRRT may also be used to safely correct hyponatremia. CRRT is less efficient in the rate at which serum sodium is changed and results in a more gradual correction over a longer time span Am J Kidney Dis. 2014;64:305. Hyponatremia in a Patient on Hemodialysis How to Manage?
  • 112. Uremia may provide some protection against osmotic demyelination Rapid correction of Na = Rapid increase in plasma osmolality High intracellular urea level
  • 114. The presence of symptoms and their severity depend on both the MAGNITUDE of the hyponatremia and the RATE at which the hyponatremia developed Home Messages
  • 115. Normal Maximal compensation for a decrease in plasma osmolality typically requires up to 48 hours. Avoid rapid correction of hyponatremia Home Messages
  • 116. 3% NaCl infusion is mandatory in: - Severe symptoms - Moderate symptoms - Acute presentation Home Messages
  • 117. Uremia may provide some protection against osmotic demyelination Home Messages